Kim, D. J., Lee, H. S., Moon, J., Sohn, S. K., Kim, H. J., Cheong, J., . . . Kim, M. K. (2017). Can we consider discontinuation of hypomethylating agents in patients with myelodysplastic syndrome: A retrospective study from The Korean Society of Hematology AML/MDS Working Party. Oncotarget.
Παραπομπή Chicago StyleKim, Da Jung, et al. "Can We Consider Discontinuation of Hypomethylating Agents in Patients With Myelodysplastic Syndrome: A Retrospective Study From The Korean Society of Hematology AML/MDS Working Party." Oncotarget 2017.
Παραπομπή MLAKim, Da Jung, et al. "Can We Consider Discontinuation of Hypomethylating Agents in Patients With Myelodysplastic Syndrome: A Retrospective Study From The Korean Society of Hematology AML/MDS Working Party." Oncotarget 2017.